Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis

流感削弱肺宿主对侵袭性肺曲霉病的先天防御

基本信息

项目摘要

PROJECT SUMMARY Fungal pathogens are a serious threat to human health. Invasive pulmonary aspergillosis (IPA) is a severe, life- threatening disease that occurs when Aspergillus fumigatus (AF) spores are inhaled into the respiratory tract and invade airway or lung tissue. More than 200,000 cases of invasive aspergillosis occur each year. A newly identified risk factor for IPA in critically ill patients is influenza infection. Influenza is a common respiratory illness that affects 5-20% of the population each year. Our long-term goal is to develop novel therapeutic interventions for use in clinical settings to prevent morbidity and mortality from IPA. The focus of this application is to identify cell signaling pathways that increase susceptibility to invasive fungal disease following influenza infection. Our preliminary data support that preceding influenza inhibits neutrophil recruitment to the lung, in contrast to post- bacterial pneumonia, and neutropenia is a key risk factor for the development of IPA. Additionally, preceding influenza inhibits neutrophil function against secondary AF infection. Furthermore, our preliminary data demonstrate that the pathogen recognition receptor, CD209a, is decreased in post-influenza IPA, suggesting that preceding influenza may inhibit fungal-sensing. Based on our preliminary data, we hypothesize that preceding influenza A infection limits innate immunity and increases susceptibility to invasive pulmonary aspergillosis by inhibiting CD209a and reducing the host response to secondary Aspergillus fumigatus infection in the lung, including neutrophil recruitment and function. Our research aims include 1) Determine whether neutrophil recruitment and effector functions are inhibited in post-influenza IPA, and 2) Determine whether suppression of CD209a-dependent AF sensing promotes post-influenza IPA. The proposed studies will increase our understanding of how influenza inhibits neutrophil migration to and function within the lung in response to subsequent AF infection (Aim1) and how the immune response to AF is initiated in the lung (Aim 2).
项目摘要 真菌病原体是对人类健康的严重威胁。侵入性肺曲霉菌病(IPA)是一种严重的生活 - 当曲霉(AF)孢子被吸入呼吸道时,发生威胁性疾病 并入侵气道或肺组织。每年发生超过200,000例侵入性曲霉病。一个新的 危重患者中IPA的鉴定危险因素是流感感染。流感是常见的呼吸道疾病 每年影响5-20%的人口。我们的长期目标是开发新颖的治疗干预措施 用于在临床环境中使用以防止IPA发病和死亡率。该应用程序的重点是确定 流感感染后增加对浸润性真菌疾病的敏感性的细胞信号通路。我们的 在流感之前的初步数据支持抑制肺中性粒细胞的募集,与后 细菌性肺炎和中性粒细胞减少是IPA发展的关键危险因素。另外,在之前 流感抑制嗜中性粒细胞功能对继发AF感染。此外,我们的初步数据 证明病原体识别受体CD209A在IMFLUENZA IPA中降低,表明 先前的流感可能会抑制真菌感应。根据我们的初步数据,我们假设 先前的流感A感染限制了先天免疫力,并增加了侵入性肺的敏感性 曲霉病通过抑制CD209A并减少对辅助曲霉感染的宿主反应 在肺中,包括中性粒细胞的募集和功能。我们的研究目的包括1)确定是否 中性粒细胞募集和效应子功能受到IMFLUENZA IPA的抑制,2)确定是否确定是否是否 CD209A依赖性AF感应的抑制会促进INFLUENZA IPA。拟议的研究将增加 我们对流感如何抑制嗜中性粒细胞迁移到肺部内部并起作用的理解 随后的AF感染(AIM1)以及如何在肺中启动对AF的免疫反应(AIM 2)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Keven Mara Robinso...的其他基金

T cell diversity during chronic inflammation
慢性炎症期间 T 细胞多样性
  • 批准号:
    10451243
    10451243
  • 财政年份:
    2022
  • 资助金额:
    $ 51.24万
    $ 51.24万
  • 项目类别:
T cell diversity during chronic inflammation
慢性炎症期间 T 细胞多样性
  • 批准号:
    10558607
    10558607
  • 财政年份:
    2022
  • 资助金额:
    $ 51.24万
    $ 51.24万
  • 项目类别:
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
流感削弱肺宿主对侵袭性肺曲霉病的先天防御
  • 批准号:
    10835161
    10835161
  • 财政年份:
    2021
  • 资助金额:
    $ 51.24万
    $ 51.24万
  • 项目类别:
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
流感削弱肺宿主对侵袭性肺曲霉病的先天防御
  • 批准号:
    10449394
    10449394
  • 财政年份:
    2021
  • 资助金额:
    $ 51.24万
    $ 51.24万
  • 项目类别:
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
流感削弱肺宿主对侵袭性肺曲霉病的先天防御
  • 批准号:
    10297248
    10297248
  • 财政年份:
    2021
  • 资助金额:
    $ 51.24万
    $ 51.24万
  • 项目类别:
Identification of Pathways and Targets in Post-influenza Invasive Pulmonary Aspergillosis
流感后侵袭性肺曲霉病的途径和靶标的确定
  • 批准号:
    10063634
    10063634
  • 财政年份:
    2020
  • 资助金额:
    $ 51.24万
    $ 51.24万
  • 项目类别:
Identification of Pathways and Targets in Post-influenza Invasive Pulmonary Aspergillosis
流感后侵袭性肺曲霉病的途径和靶标的确定
  • 批准号:
    10224339
    10224339
  • 财政年份:
    2020
  • 资助金额:
    $ 51.24万
    $ 51.24万
  • 项目类别:
Role of IL-33 in Influenza and Staphylococcus aureus Co-infection
IL-33 在流感和金黄色葡萄球菌合并感染中的作用
  • 批准号:
    9320979
    9320979
  • 财政年份:
    2016
  • 资助金额:
    $ 51.24万
    $ 51.24万
  • 项目类别:
Role of IL-33 in Influenza and Staphylococcus aureus Co-infection
IL-33 在流感和金黄色葡萄球菌合并感染中的作用
  • 批准号:
    9751941
    9751941
  • 财政年份:
    2016
  • 资助金额:
    $ 51.24万
    $ 51.24万
  • 项目类别:

相似国自然基金

海洋缺氧对持久性有机污染物入海后降解行为的影响
  • 批准号:
    42377396
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
  • 批准号:
    32371616
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
  • 批准号:
    22379027
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
  • 批准号:
    32300624
  • 批准年份:
    2023
  • 资助金额:
    10 万元
  • 项目类别:
    青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
  • 批准号:
    52377215
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity
SARS-CoV-2 免疫失调对抗真菌免疫的影响
  • 批准号:
    10658355
    10658355
  • 财政年份:
    2023
  • 资助金额:
    $ 51.24万
    $ 51.24万
  • 项目类别:
Mechanistic Investigation of Gut Mycobiota in the Regulation of Lung Immunity and Disease
肠道菌群调节肺部免疫和疾病的机制研究
  • 批准号:
    10793853
    10793853
  • 财政年份:
    2023
  • 资助金额:
    $ 51.24万
    $ 51.24万
  • 项目类别:
Lymph node stromal cells coordinate immune cell environments during Aspergillus fumigatus infection
烟曲霉感染期间淋巴结基质细胞协调免疫细胞环境
  • 批准号:
    10751936
    10751936
  • 财政年份:
    2023
  • 资助金额:
    $ 51.24万
    $ 51.24万
  • 项目类别:
The role of IFNAR2 in regulation of damage during A. fumigatus lung infection
IFNAR2 在烟曲霉肺部感染损伤调节中的作用
  • 批准号:
    10650703
    10650703
  • 财政年份:
    2022
  • 资助金额:
    $ 51.24万
    $ 51.24万
  • 项目类别:
Mechanistic Investigation of Gut Mycobiota in the Regulation of Lung Immunity and Disease
肠道菌群调节肺部免疫和疾病的机制研究
  • 批准号:
    10371348
    10371348
  • 财政年份:
    2022
  • 资助金额:
    $ 51.24万
    $ 51.24万
  • 项目类别: